Grant Name |
Close Date |
A Liquid-Biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-Inhibitor Resistant ER+/HER2- Metastatic Breast Cancer |
9/30/2027 |
A Liquid-Biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-Inhibitor Resistant ER+/HER2- Metastatic Breast Cancer |
9/30/2027 |
A Phase III Non-Inferiority Randomized Controlled Trial (RCT) of Fixed-Duration Daratumumab Versus Continuous Daratumumab Among Transplant Ineligible Older Adults with Newly-Diagnosed Multiple Myeloma |
10/31/2031 |
A Randomized Trial of Partial Breast Irradiation |
9/30/2028 |
A Randomized Trial of Regional Radiotherapy in Luminal A Breast Cancer |
6/30/2025 |
A pilot randomized, double-placebo controlled trial of sublingual or oral immunotherapy for tree nut allergy (TRADE) |
9/30/2027 |
Addressing cardiovascular co-morbidities in patients with cancer (C3) |
11/30/2024 |
Androgen Suppression Combined with Elective Nodal and a Dose Escalated Boost. A Non-Inferiority, Phase 3 Randomized Controlled Trial of Stereotactic Body Radiation Therapy versus Brachytherapy Boost (ASCENDE-SBRT) |
3/31/2032 |
Building system capacity for home visits for patients near the end of life: A mixed methods study |
3/31/2026 |
Canada Research Chair - Tier 2 |
3/31/2026 |
Canada Research Chair - Tier 2 |
3/31/2026 |
Canadian Cancer Rehabilitation (CanRehab) Team: Improving the systematic identification, management, and treatment of the adverse effects of cancer. |
11/30/2024 |
Canadian Network for Statistical Training in Trials (CANSTAT) |
8/31/2025 |
Canadian Network for Statistical Training in Trials (CANSTAT) |
8/31/2025 |
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Multicentre Phase II/III Randomised Controlled Trial (DYNAMIC-III) |
9/30/2027 |
Defining clinically important bleeding outcomes for clinical trials in hematological malignancies: perceptions of patients and health care providers |
3/31/2024 |
Development of a Personalized Epigenetic Maintenance Approach for AML and MDS Patients after Allogeneic Stem Cell Transplantation |
9/30/2024 |
Development of a Personalized Epigenetic Maintenance Approach for AML and MDS Patients after Allogeneic Stem Cell Transplantation |
12/31/2024 |
Early discontinuation of antibiotics for unexplained febrile neutropenia: a pilot randomized controlled trial- EASE ANTIBIOTICS pilot trial |
9/30/2025 |
Evaluating the palliative and end-of-life care of older Canadians living and dying with dementia |
9/30/2024 |
Further Refinement and Multi-country Validation of a Preliminary Set of Quality Indicators for Palliative Care |
3/31/2025 |
Generating an Off the Shelf T-Cell Therapy Using Covalent Immune Recruiters |
4/30/2026 |
Integrated Precision Medicine Technology and Approach for Optimal Drug Therapy for Canadians |
7/31/2025 |
Kaiso, Triple Negative Breast Cancer and Women of African Ancestry. |
9/30/2025 |
Long-term results of the LUMINA prospective cohort study evaluating the risk of local recurrence in low Risk luminal a breast cancer |
12/31/2024 |
Metabolic targeting of AML cells in their microenvironment |
6/30/2025 |
Minimal Residual Disease (MRD) Research Laboratory to Target Acute Myeloid Leukemia |
11/11/2025 |
PREVENT GU: Prevention of thromboembolism with rivaroxaban in GU cancer patients receiving chemotherapy: A Randomized Placebo-Controlled, Double-Blind Clinical Trial |
3/31/2026 |
Prospective Evaluation of Breast-Conserving Surgery Alone in Low Risk Ductal Carcinoma in Situ Defined by a Molecular Expression Assay Combined with Clinico-Pathological Features |
9/30/2026 |
Retaining and Attracting Workers in Long-Term Care Homes: How System Dynamics Can Help |
9/30/2024 |
Salary Support Award for Dr. Greg Pond |
3/31/2025 |
Targeting responsive microenvironment to prevent relapse of human acute myeloid leukemia |
1/31/2025 |
The TACtful Trial: A first-in-human multi-centre trial of BCMA specific T-cell antigen coupler infusion, generated from cryopreserved G-CSF-mobilized peripheral blood, in patients with relapsed and refractory multiple myeloma. |
9/30/2028 |
Understanding the intersection of frailty, sepsis, and cancer: Rehabilitation to improve survivor outcomes (the I-CaRe project) |
6/1/2024 |
Validation of a novel biomarker classifier that predicts radiation response following breast-conserving surgery for ductal carcinoma in situ (DCIS) |
3/31/2027 |
Virtualizing survivorship: Implementing a more timely and comprehensive model of follow-up care |
11/30/2024 |
oPTion-DDR: A randomized phase III trial investigating Platinum and Taxane chemotherapy in metastatic castration resistant prostate cancer patients with alterations in DNA Damage Response (DDR) genes |
12/31/2029 |